This information was published on 2025-10-21T00:07:48 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2564692 (IR 1863305) |
| (220) |
21 May 2025
|
| (300) |
KR, 20 May 2025, 4020250085838
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Injectable pharmaceutical preparations for medical purposes [biomaterials for tissue restoration]; injectable dermal fillers; surgical implants comprised of living tissues; biomaterials for tissue restoration; pharmaceutical preparations for use as dermal fillers; medical preparations for use as dermal fillers; dermatological filler preparations; implants comprising living tissue; bone void fillers comprised of living tissues; pre-filled syringes containing medical filler preparations; biological preparations for medical purposes; skin hydrators being injectable dermal fillers; tissue-regenerative pharmaceutical preparations; dermatological preparations; pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; collagen for medical purposes; drugs for medical purposes; medicines for human purposes; chemico-pharmaceutical preparations; dietary supplements for human beings; nutritional supplements; nutraceutical preparations for therapeutic or medical purposes. |
| (540) | REJURAN |
| (550) | Word |
| (730) |
Pharmaresearch Co., Ltd.
|
Find out more about publications on the About page.